Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FU052
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $77,252
Award facts
- Contract value 100% obligated
- $77,251.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors with a ceiling value of $77,251.74. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 21, 2025. Dupixent is a biologic medication commonly prescribed for moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making it a critical pharmaceutical supply for military healthcare systems.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies supporting Defense Health Agency operations and military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial portfolio of federal medical procurement contracts with the DLA Medical Supply Chain, demonstrating its capability to fulfill both routine and specialized pharmaceutical requirements for the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26FU052?
SPE2DR26FU052 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FU052 worth?
The government has obligated $77,252 on SPE2DR26FU052.
Is contract SPE2DR26FU052 an order under another contract?
Yes. SPE2DR26FU052 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU052 competed?
The extent of competition for SPE2DR26FU052 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award